|
Volumn 18, Issue 5, 2010, Pages 401-402
|
Unfavorable drug interactions in targeted breast cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERYTHROPOIETIN RECEPTOR;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
JANUS KINASE 2;
PHOSPHATIDYLINOSITOL 3 KINASE;
RECOMBINANT ERYTHROPOIETIN;
STAT PROTEIN;
TRASTUZUMAB;
ANEMIA;
BLOOD TRANSFUSION;
BONE MARROW CELL;
BREAST CANCER;
BREAST TUMOR;
CANCER CELL;
CANCER CHEMOTHERAPY;
CELL PROLIFERATION;
DOWN REGULATION;
DRUG BINDING;
HUMAN;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
THERAPY EFFECT;
TREATMENT FAILURE;
|
EID: 78249241503
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccr.2010.10.027 Document Type: Short Survey |
Times cited : (3)
|
References (10)
|